Actively Recruiting
ESP Block in MIS Lumbar Spine Surgery
Led by Hospital for Special Surgery, New York · Updated on 2025-10-06
48
Participants Needed
1
Research Sites
165 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, randomized controlled trial of patients undergoing minimally invasive transforaminal lumbar interbody fusion. This study will randomize patients into one of two groups: erector spinae plane (ESP) block and no ESP block.
CONDITIONS
Official Title
ESP Block in MIS Lumbar Spine Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-80 years
- Patients scheduled for minimally invasive transforaminal lumbar interbody fusion (MIS TLIF) at any spinal level with the principal investigator
- Physical status ASA classification 1, 2, or 3
You will not qualify if you...
- Physical status ASA classification 4 or higher
- Body mass index (BMI) greater than 40
- Chronic opioid use defined as daily use for more than 3 months
- History of previous lumbar spine surgery or revision surgery
- Allergy to any study medications
- Non-English speaking
- Chronic kidney problems with creatinine over 2 or severe liver disease such as cirrhosis or liver failure
- Pregnancy
- Undergoing any additional surgeries at the same time
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital for Special Surgery
New York, New York, United States, 10021
Actively Recruiting
Research Team
S
Sheeraz Qureshi, MD, MBA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here